Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      Phase II Study of Ipilimumab Monotherapy in Recurrent Platinum-sensitive Ovarian Cancer
      Description

      To assess the incidence of drug-related adverse events of Grade 3 or higher and the overall response associated with ipilimumab treatment

      Conditions
      Platinum-sensitive Ovarian Cancer, Second-line, Third-line, or Fourth-line
      Talk to us